9 results on '"James D Stefaniak"'
Search Results
2. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study
- Author
-
Audrey Low, Maria A. Prats-Sedano, Elizabeth McKiernan, Stephen F. Carter, James D. Stefaniak, Stefania Nannoni, Li Su, Maria-Eleni Dounavi, Graciela Muniz-Terrera, Karen Ritchie, Brian Lawlor, Lorina Naci, Paresh Malhotra, Clare Mackay, Ivan Koychev, Craig W. Ritchie, Hugh S. Markus, and John T. O’Brien
- Subjects
Alzheimer’s disease ,Cerebral small vessel disease ,Modifiable risk factors ,APOE4 ,Lifestyle ,Prevention ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background Considerable overlap exists between the risk factors of dementia and cerebral small vessel disease (SVD). However, studies remain limited to older cohorts wherein pathologies of both dementia (e.g. amyloid) and SVD (e.g. white matter hyperintensities) already co-exist. In younger asymptomatic adults, we investigated differential associations and interactions of modifiable and non-modifiable inherited risk factors of (future) late-life dementia to (present-day) mid-life SVD. Methods Cognitively healthy middle-aged adults (aged 40–59; mean 51.2 years) underwent 3T MRI (n = 630) as part of the PREVENT-Dementia study. To assess SVD, we quantified white matter hyperintensities, enlarged perivascular spaces, microbleeds, lacunes, and computed composite scores of SVD burden and subtypes of hypertensive arteriopathy and cerebral amyloid angiopathy (CAA). Non-modifiable (inherited) risk factors were APOE4 status and parental family history of dementia. Modifiable risk factors were derived from the 2020 Lancet Commission on dementia prevention (early/midlife: education, hypertension, obesity, alcohol, hearing impairment, head injuries). Confirmatory factor analysis (CFA) was used to evaluate the latent variables of SVD and risk factors. Structural equation modelling (SEM) of the full structural assessed associations of SVD with risk factors and APOE4*risk interaction. Results In SEM, the latent variable of global SVD related to the latent variable of modifiable midlife risk SVD (β = 0.80, p = .009) but not non-modifiable inherited risk factors of APOE4 or family history of dementia. Interaction analysis demonstrated that the effect of modifiable risk on SVD was amplified in APOE4 non-carriers (β = − 0.31, p = .009), rather than carriers. These associations and interaction effects were observed in relation to the SVD subtype of hypertensive arteriopathy, rather than CAA. Sensitivity analyses using separate general linear models validated SEM results. Conclusions Established modifiable risk factors of future (late-life) dementia related to present-day (mid-life) SVD, suggesting that early lifestyle modifications could potentially reduce rates of vascular cognitive impairment attributed to SVD, a major ‘silent’ contributor to global dementia cases. This association was amplified in APOE4 non-carriers, suggesting that lifestyle modifications could be effective even in those with genetic predisposition to dementia.
- Published
- 2022
- Full Text
- View/download PDF
3. Auditory beat perception is related to speech output fluency in post-stroke aphasia
- Author
-
James D. Stefaniak, Matthew A. Lambon Ralph, Blanca De Dios Perez, Timothy D. Griffiths, and Manon Grube
- Subjects
Medicine ,Science - Abstract
Abstract Aphasia affects at least one third of stroke survivors, and there is increasing awareness that more fundamental deficits in auditory processing might contribute to impaired language performance in such individuals. We performed a comprehensive battery of psychoacoustic tasks assessing the perception of tone pairs and sequences across the domains of pitch, rhythm and timbre in 17 individuals with post-stroke aphasia and 17 controls. At the level of individual differences we demonstrated a correlation between metrical pattern (beat) perception and speech output fluency with strong effect (Spearman’s rho = 0.72). This dissociated from more basic auditory timing perception, which did not correlate with output fluency. This was also specific in terms of the language and cognitive measures, amongst which phonological, semantic and executive function did not correlate with beat detection. We interpret the data in terms of a requirement for the analysis of the metrical structure of sound to construct fluent output, with both being a function of higher-order “temporal scaffolding”. The beat perception task herein allows measurement of timing analysis without any need to account for motor output deficit, and could be a potential clinical tool to examine this. This work suggests strategies to improve fluency after stroke by training in metrical pattern perception.
- Published
- 2021
- Full Text
- View/download PDF
4. Language networks in aphasia and health: A 1000 participant activation likelihood estimation meta-analysis
- Author
-
James D. Stefaniak, Reem S.W. Alyahya, and Matthew A. Lambon Ralph
- Subjects
Meta-analysis ,fMRI ,PET ,Plasticity ,Language ,Stroke ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Aphasia recovery post-stroke is classically and most commonly hypothesised to rely on regions that were not involved in language premorbidly, through ‘neurocomputational invasion’ or engagement of ‘quiescent homologues’. Contemporary accounts have suggested, instead, that recovery might be supported by under-utilised areas of the premorbid language network, which are downregulated in health to save neural resources (‘variable neurodisplacement’). Despite the importance of understanding the neural bases of language recovery clinically and theoretically, there is no consensus as to which specific regions are more likely to be activated in post-stroke aphasia (PSA) than healthy individuals. Accordingly, we performed an Activation Likelihood Estimation (ALE) meta-analysis of language functional neuroimaging studies in PSA. We obtained coordinate-based functional neuroimaging data for 481 individuals with aphasia following left-hemisphere stroke and 530 linked controls from 33 studies that met predefined inclusion criteria. ALE identified regions of consistent, above-chance spatial convergence of activation, as well as regions of significantly different activation likelihood, between participant groups and language tasks. Overall, these findings dispute the prevailing theory that aphasia recovery involves recruitment of novel right hemisphere territory into the language network post-stroke. Instead, multiple regions throughout both hemispheres were consistently activated during language tasks in both PSA and controls. Regions of the right anterior insula, frontal operculum and inferior frontal gyrus (IFG) pars opercularis were more likely to be activated across all language tasks in PSA than controls. Similar regions were more likely to be activated during higher than lower demand comprehension or production tasks, consistent with them representing enhanced utilisation of spare capacity within right hemisphere executive-control related regions. This provides novel evidence that ‘variable neurodisplacement’ underlies language network changes that occur post-stroke. Conversely, multiple undamaged regions were less likely to be activated across all language tasks in PSA than controls, including domain-general regions of medial superior frontal and paracingulate cortex, right IFG pars triangularis and temporal pole. These changes might represent functional diaschisis, and demonstrate that there is not global, undifferentiated upregulation of all domain-general neural resources during language in PSA. Such knowledge is essential if we are to design neurobiologically-informed therapeutic interventions to facilitate language recovery.
- Published
- 2021
- Full Text
- View/download PDF
5. Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
- Author
-
Audrey Low, Elijah Mak, James D. Stefaniak, Maura Malpetti, Nicolas Nicastro, George Savulich, Leonidas Chouliaras, Hugh S. Markus, James B. Rowe, and John T. O’Brien
- Subjects
small vessel disease ,magnetic resonance imaging ,diffusion tensor imaging ,white matter hyperintensities ,cognition ,dementia ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
BackgroundThe peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition.Methods145 participants underwent 3T brain MRI and cognitive assessment. 112 were patients with mild cognitive impairment, Alzheimer’s disease, progressive supranuclear palsy, dementia with Lewy bodies, or frontotemporal dementia. PSMD, SVD burden [white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), microbleeds, lacunes], average mean diffusivity (MD), gray matter (GM), white matter (WM), and total intracranial volume were quantified. Robust linear regression was conducted to examine associations between variables. Dominance analysis assessed the relative importance of markers in predicting various outcomes. Regional analyses examined spatial overlap between PSMD and WMH.ResultsPSMD was associated with global and regional SVD measures, especially WMH and microbleeds. Dominance analysis demonstrated that among SVD markers, WMH was the strongest predictor of PSMD. Furthermore, PSMD was more closely associated to WMH than with GM and WM volumes. PSMD was associated with WMH across all regions, and correlations were not significantly stronger in corresponding regions (e.g., frontal PSMD and frontal WMH) compared to non-corresponding regions. PSMD outperformed all four conventional SVD markers and MD in predicting cognition, but was comparable to GM and WM volumes.DiscussionPSMD was robustly associated with established SVD markers. This new measure appears to be a marker of diffuse brain injury, largely due to vascular pathology, and may be a useful and convenient metric of overall cerebrovascular burden.
- Published
- 2020
- Full Text
- View/download PDF
6. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study
- Author
-
Craig W. Ritchie, Graciela Muniz-Terrera, Maria-Eleni Dounavi, Hugh S. Markus, Elijah Mak, Li Su, John T. O'Brien, Audrey Low, James D Stefaniak, Karen Ritchie, Low, Audrey [0000-0002-2520-454X], Mak, Elijah [0000-0002-6437-8024], Dounavi, Maria [0000-0001-8287-346X], Markus, Hugh [0000-0002-9794-5996], O'Brien, John [0000-0002-0837-5080], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,Male ,Aging ,Inflammasomes ,Apolipoprotein E4 ,Disease ,Fibrinogen ,Healthy Aging ,0302 clinical medicine ,Cognition ,White matter hyperintensities ,Medicine ,Family history ,Episodic memory ,General Neuroscience ,Regular Article ,Middle Aged ,Alzheimer's disease ,White Matter ,C-Reactive Protein ,Cardiology ,Disease Progression ,Female ,medicine.symptom ,Cerebral microbleeds ,medicine.drug ,Risk ,medicine.medical_specialty ,Heterozygote ,APOE4 ,Cerebral small vessel disease ,Inflammation ,03 medical and health sciences ,Alzheimer Disease ,Internal medicine ,mental disorders ,Dementia ,Humans ,Genetic Predisposition to Disease ,Genetic Association Studies ,business.industry ,medicine.disease ,Hyperintensity ,030104 developmental biology ,Risk factors ,Cerebral Small Vessel Diseases ,Neurology (clinical) ,Small vessel ,Geriatrics and Gerontology ,business ,030217 neurology & neurosurgery ,Biomarkers ,Developmental Biology - Abstract
Cerebral small vessel disease (SVD) and inflammation are increasingly recognized as key contributors to Alzheimer's disease (AD), although the timing, trajectory, and relation between them early in the disease process is unclear. Therefore, to investigate very early-stage changes, we compared 158 healthy midlife adults with and without inherited AD predisposition (APOE4 carriership (38% positive), parental family history (FH) of dementia (54% positive)) on markers of SVD (white matter hyperintensities (WMH), cerebral microbleeds), and inflammation (C-reactive protein (CRP), fibrinogen), cross-sectionally and longitudinally over two years. While WMH severity was comparable between groups at baseline, longitudinal progression of WMH was greater in at-risk groups (APOE4+ and FH+). Topographically, APOE4 was associated exclusively with deep, but not periventricular, WMH progression after adjusting for FH. Conversely, APOE4 carriers displayed lower CRP levels than noncarriers, but not fibrinogen. Furthermore, interaction analysis showed that FH moderated the effect of SVD and inflammation on reaction time, an early feature of SVD, but not episodic memory or executive function. Findings suggest that vascular and inflammatory changes could occur decades before dementia onset, and may be of relevance in predicting incipient clinical progression., Highlights • Heritable risk factors related to SVD progression, despite lower levels of inflammation. • SVD progression had more pronounced adverse effects on reaction time in at-risk individuals. • Association between SVD and inflammation was stronger in those at-risk.
- Published
- 2020
- Full Text
- View/download PDF
7. Discontinuation and non-publication of neurodegenerative disease trials:a cross-sectional analysis
- Author
-
T. C. H. Lam, James D. Stefaniak, N. E. Sim, David P. Breen, and R. Al-Shahi Salman
- Subjects
Research design ,medicine.medical_specialty ,Blinding ,Databases, Factual ,Cross-sectional study ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,Neurodegenerative Diseases/drug therapy ,Journal Article ,medicine ,Humans ,030212 general & internal medicine ,Publishing ,Clinical Trials as Topic ,business.industry ,Information Dissemination ,Neurodegenerative Diseases ,Odds ratio ,Confidence interval ,Discontinuation ,Clinical trial ,Cross-Sectional Studies ,Neurology ,Research Design ,Physical therapy ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND AND PURPOSE: Trial discontinuation and non-publication represent major sources of research waste in clinical medicine. No previous studies have investigated non-dissemination bias in clinical trials of neurodegenerative diseases.METHODS: ClinicalTrials.gov was searched for all randomized, interventional, phase II-IV trials that were registered between 1 January 2000 and 31 December 2009 and included adults with Alzheimer's disease, motor neurone disease, multiple sclerosis or Parkinson's disease. Publications from these trials were identified by extensive online searching and contact with authors, and multiple logistic regression analysis was performed to identify characteristics associated with trial discontinuation and non-publication.RESULTS: In all, 362 eligible trials were identified, of which 12% (42/362) were discontinued. 28% (91/320) of completed trials remained unpublished after 5 years. Trial discontinuation was independently associated with number of patients (P = 0.015; more likely in trials with ≤100 patients; odds ratio 2.65, 95% confidence interval 1.21-5.78) and phase of trial (P = 0.009; more likely in phase IV than phase III trials; odds ratio 3.90, 95% confidence interval 1.41-10.83). Trial non-publication was independently associated with blinding status (P = 0.005; more likely in single-blind than double-blind trials; odds ratio 5.63, 95% confidence interval 1.70-18.71), number of centres (P = 0.010; more likely in single-centre than multi-centre trials; odds ratio 2.49, 95% confidence interval 1.25-4.99), phase of trial (P = 0.041; more likely in phase II than phase IV trials; odds ratio 2.88, 95% confidence interval 1.04-7.93) and sponsor category (P = 0.001; more likely in industry-sponsored than university-sponsored trials; odds ratio 5.05, 95% confidence interval 1.87-13.63).CONCLUSIONS: There is evidence of non-dissemination bias in randomized trials of interventions for neurodegenerative diseases. Associations with trial discontinuation and non-publication were similar to findings in other diseases. These biases may distort the therapeutic information available to inform clinical practice.
- Published
- 2017
- Full Text
- View/download PDF
8. HIV/AIDS presenting with stroke-like features caused by cerebral Nocardia abscesses: a case report
- Author
-
James D. Stefaniak
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Neurology ,medicine.medical_treatment ,Clinical Neurology ,Brain Abscess ,Nocardia Infections ,HIV Infections ,Case Report ,Nocardia ,Diagnosis, Differential ,Acquired immunodeficiency syndrome (AIDS) ,Diplopia ,Humans ,Medicine ,Confusion ,Abscess ,Stroke ,Brain abscess ,biology ,business.industry ,Headache ,Immunosuppression ,General Medicine ,Middle Aged ,medicine.disease ,biology.organism_classification ,Paresis ,Acquired Immune Deficiency Syndrome ,Sensation Disorders ,Immunology ,Opportunistic ,Neurology (clinical) ,business ,Human Immunodeficiency Virus - Abstract
Background Immunosuppression in Human Immunodeficiency Virus can predispose to opportunistic infections of the central nervous system and can be life threatening without early recognition and management. This can be delayed in undiagnosed Human Immunodeficiency Virus. The present article is the only case report in the literature to describe a first presentation of Acquired Immune Deficiency Syndrome as cerebral Nocardia abscesses that were initially treated as a stroke. Case presentation A previously well 59 year old Caucasian man presented with sudden onset of left sided hemiparesis and sensory change, right sided headache, diplopia and confusion. The patient was initially treated as a stroke but was eventually found to have pulmonary and cerebral Nocardia abscesses secondary to a new diagnosis of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome. Conclusion Human Immunodeficiency Virus infection can produce a variety of neurological presentations with the added possibility of multiple pathological processes being present simultaneously. This is only further complicated in instances, such as the present case, when Human Immunodeficiency Virus infection has not yet been diagnosed. It is therefore imperative that appropriate neuroimaging is done at an early stage to ensure timely initiation of appropriate therapy. Cerebral Nocardia abscesses are a serious and potentially life threatening complication of Human Immunodeficiency Virus.
- Full Text
- View/download PDF
9. Electrophysiological Determinants for Arrhythmogenesis Following Premature Stimulation In Murine Hearts
- Author
-
Yanhui R. Zhang, Christopher L.-H. Huang, James D. Stefaniak, Rudolf Duehmke, Iman S. Gurung, Andrew A. Grace, and Laila Guzadhur
- Subjects
medicine.medical_specialty ,Refractory period ,business.industry ,Action potential amplitude ,Biophysics ,Stimulation ,Stimulus (physiology) ,Ventricular effective refractory period ,musculoskeletal system ,Nerve conduction velocity ,Electrophysiology ,Internal medicine ,medicine ,Cardiology ,Analysis of variance ,business - Abstract
Background: Circus type re-entry is classically associated with reduced action potential (AP) conduction velocity through partially refractory tissue resulting in unidirectional conduction block. We assessed the extent to which premature extrasystolic APs under such conditions resulted in ventricular arrhythmogenesis in isolated Langendorff-perfused murine hearts.Methods and Results: A novel programmed electrical stimulation (PES) protocol applied trains of 8 S1 stimuli at 100 ms intervals followed by extrasystolic S2 stimuli at successively decreasing S1S2 intervals. S2 stimulus strengths required to overcome refractoriness, reduce ventricular effective refractory period (VERP) and thereby elicit extrasystolic APs, increased with shortened S1S2 intervals, despite constant durations at 90% recovery (APD90) of the preceding APs. Critical interval, CI, the difference APD90-VERP, consequently increased with stimulus strength. The corresponding latencies and peak amplitudes of the extrasystolic APs consequently sharply increased and decreased respectively with CI thereby potentially replicating necessary conditions for re-entrant, circus-type, arrhythmia. The dependence of CI upon stimulus strength tended to consistent limiting values expected from approaches to absolute refractory periods. These values were greater in arrhythmogenic (mean CI 18.9±0.55 ms, n=4) than in non-arrhythmogenic hearts (mean CI 15.1±0.37, n=4; P=0.001, ANOVA), despite their statistically indistinguishable APD90 (arrhythmogenic hearts: 40.9±2.23 ms, n=4 vs non-arrhythmogenic hearts: 36.5±2.61ms, n=4; p>0.05, ANOVA) or VERP values (arrhythmogenic hearts: 22.5±2.66 ms, n=4 vs non-arrhythmogenic hearts: 21.8±2.53 ms, n=4; p>0.05, ANOVA).Conclusions: These findings suggest existence of a specific CI (CI∗) in turn corresponding to specific conditions of latency and action potential amplitude that would be sufficient to result in arrhythmogenesis.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.